Generics 60

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Apixaban manufacturers

60 products found

Filters

60 products found

apixaban

Oral suspension 2.5 mg/2 ml - 75 ml; 100ml; 150ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
United Kingdom
Available for
Licensing with supply
Comments
Patented formulation + 5ml syringe
Manufacturer #8593
It is a private R&D and business development organization established in the 2000s, specializing in the design and development of new pharmaceutical products worldwide. They have an average of 5-6 new developments per year, an average of 8-10 DCPs per year, more than 60 dossier updates in the last 10 years, they have more than 3 valid and approved patent applications, and approximately 140 MAs worldwide.

Manufacturer usually replies in 2 days

apixaban

Tablets, film coated 2.5 mg, 5 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Albania , Armenia , Azerbaijan , Cyprus , Estonia , Greece , Israel , Kazakhstan , Kosovo , Latvia , Lithuania , Philippines , Tajikistan , Uzbekistan , Vietnam
Available for
Licensing with supply, Distribution only
Manufacturer #17046

It is one of the fastest-growing pharmaceutical firms and a top investor in Rx and Healthcare solutions. The company has been awarded several prizes for its performance and growing business units and has recently been characterized as one of the local economy gems. Based in Europe.

Manufacturer usually replies in 6 days

apixaban

Tablets, film coated 2.5 mg, 5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Available for
Licensing with supply
Manufacturer #16163
As a result of a strategic agreement with a company delivering an attractive high-quality portfolio with European supply, it is a trustworthy B2B partner with more than 30 years of experience in the out-licensing business model. The organization is a reliable commercial partner that takes a customer-centric approach and strives for long-term partnership development to secure market success.

Manufacturer usually replies in 6 days

apixaban

Tablets, film coated 2.5 mg, 5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Eliquis®
Manufacturer #252

Manufacturer usually replies in 2 days

apixaban

Tablets, film coated 2.5 mg , 5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Comments
Reference product: Eliquis
Manufacturer #19112
A pharmaceutical manufacturer based in the EU that develops and produces generic medicines and sells its products in the EU, North America, LATAM, and Africa. Main therapeutic areas include diabetes, urology, and antidepressant. The company possesses its own R&D and regulatory department.

Manufacturer usually replies in 7 days

apixaban

Tablets, film coated 2.5 mg, 5 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Dossier availability date: Q3 2024, RMS: LV
Manufacturer #422

A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

apixaban

Tablets, film coated 2.5mg, 5mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Available for
Distribution only
Manufacturer #1250

Manufacturer usually replies in 7 days

apixaban

Tablets, immediate release (IR) 2.5 mg, 5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Eliquis (Bristol-Myers, Squibb / Pfizer, EEIG)
Manufacturer #263
A pharmaceutical manufacturer based in the EU that has been active in 70+ countries selling its products all over the world for 40+ years. Key production lines are Rx, nutraceuticals, and medical devices. The company's production lines are GMP-compliant. The main dosage form is a solid oral dosage form.

Manufacturer usually replies in 9 days

apixaban

Tablets, film coated 2.5 mg, 5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
EU MA's Running, MA’s Available
Manufacturer #21467

Manufacturer usually replies in 9 days

apixaban

Tablets 2.5 mg, 5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref:Eliquis® (Bristol-Myers)
Manufacturer #10578

Manufacturer usually replies in 6 days

apixaban

Tablets, film coated 2.5 mg, 5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #15070

A pharmaceutical manufacturer based in the EU that is selling its products in EU, CIS, and Asia. Key production lines are Rx, OTC, medical devices, and nutraceuticals. The company's production lines are EU GMP-compliant.

Manufacturer usually replies in 8 days

apixaban

Tablets, film coated 2.5 mg, 5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Eliquis®,BMS/Pfizer
Manufacturer #8822
A pharmaceutical manufacturer based in Europe that has been active in 60+ countries selling its products in Europe, North America, LATAM, MENA, and Asia for 50+ years. The main therapeutic areas include CNS, ophthalmology, and dermatology. Main dosage forms include sterile and solid oral dosage forms. The company's production lines are cGMP-compliant. The company possesses branches in Europe, North America, and Asia.

Manufacturer usually replies in 5 days

apixaban

Tablets, film coated 2.5 mg, 5 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Dossier availability date: Q4 2024
Manufacturer #519

Manufacturer usually replies in 6 days

apixaban

Oral solution 1 mg/ml

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Reference product: Eliquis
Manufacturer #19112
A pharmaceutical manufacturer based in the EU that develops and produces generic medicines and sells its products in the EU, North America, LATAM, and Africa. Main therapeutic areas include diabetes, urology, and antidepressant. The company possesses its own R&D and regulatory department.

Manufacturer usually replies in 7 days

apixaban

Tablets, film coated 2.5 mg, 5 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Eliquis
Manufacturer #15925
The global pharmaceutical manufacturer that deals with affordable but high-quality drugs that help in getting exceptional aftercare services in terms of pharmaceutical products. Their products are innovated and made at the lab and then completely tested so that the best results could be achieved.

Manufacturer usually replies in 7 days

apixaban

Tablets, film coated 2.5 mg, 5 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Estonia , Latvia , Lithuania
Comments
Dossier availability date: Q4 2023
Manufacturer #2346

Manufacturer usually replies in 7 days

apixaban

Tablets 2.5 mg, 5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Licensing with supply, Technology transfer
Manufacturer #260
Pharmaceutical manufacturer operating in the EU for 50+ years. Activities include scientific development, manufacturing, out-licensing, marketing, and distribution of high-quality generic medicines. The company owns several production facilities that all comply with EU GMP requirements. Key dosage forms include conventional solids, cytostatic injectables, and cytostatic orals. The company holds an in-house R&D and Intellectual property business unit, as well as a regulatory affairs team that prepares CTD dossiers and maintains direct contact with regulatory agencies worldwide. The portfolio includes more than three thousand MA sets approved in the EU while hundreds of MA are in progress. Key therapy lines are cardiovascular, CNS, diabetes, immunology, oncology, and more. The company is active in nearly 100 countries worldwide, selling its products in Africa, Asia, Australia, Europe, LATAM, and the Middle East.

Manufacturer usually replies in 12 days

apixaban

Tablets, film coated 2.5 mg, 5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Portugal , Vietnam
Manufacturer #437
A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products in Europe, North America, LATAM, Africa, Middle East, and Asia for 40+ years. Main therapeutics areas include the nervous system, cardiometabolic, and women’s health. The company's production lines are GMP-compliant. The main dosage forms are solid, semi-solid, liquid, and suspension. The company owns branches in the EU, Africa, and LATAM.

Manufacturer usually replies in 11 days

apixaban

Tablets, film coated 2.5mg, 5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Iceland
GMP approvals
EU GMP
Manufacturer #28915

Manufacturer usually replies in 16 days

apixaban

Tablets 2.5 mg, 5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #31058

Want to view all 60 products? Create your free account today!

Apixaban Manufacturers

Apixaban is an anticoagulant that is classified as a Factor Xa inhibitor and is commonly marketed as Eliquis. It works by acting upon and inhibiting Factor Xa in the coagulation cascade and thus preventing clot formation. This pharmaceutical medicine is primarily used to prevent stroke in patients with atrial fibrillation. Furthermore, it is used post-operatively after hip and knee surgery to prevent the risk of Deep Venous Thrombosis (DVT) and in extension Pulmonary Embolism (PE). It is also used to treat both these conditions, and for secondary prevention after the first attack has occurred. Apixaban is strictly prohibited if the patient has an active bleeding disorder, liver disease, renal disease, or Anti-phospholipid antibody syndrome. Moreover, this pharmaceutical remedy should not be administered if the patient has a history of hypersensitivity to the drug or its constituents, or if the patient has prosthetic heart valves. There are certain side effects that need to be looked out for while taking this pharmaceutical medicine. They include allergic reactions, skin rash, fainting spells, and nausea. The ones that warrant immediate attention are easy bruising, heavy menses, dizziness, headache, bleeding from unusual sites, prolonged bleeding, brown urine, bloody stools, and numbness or restricted movement of the limbs. Apixaban is available for oral administration in the form of tablets. It has to be taken twice a day with or without food. It is available in two doses: 2.5 mg and 5 mg. Apixaban was approved by the Food and Drug Administration (FDA) for use after hip and knee surgery on March 18, 2014, and for treatment and prevention of DVT And PE on August 21, 2014. This pharmaceutical medicine is not approved for use during pregnancy or lactation.

How does Apixaban Work?

It works by thinning the blood, thereby reducing the chances of clot formation. Apixaban suppresses factor Xa in both it is free and post-processed, regardless of the presence of antithrombin IIILabel. ProthrominaseLabel is also inhibited by apixaban. The creation of a thrombus is prevented by these effects. Apixaban is used to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation, as well as for the prevention of deep vein thrombosis (DVT) leading to pulmonary embolism (PE) in patients who have had hip or knee replacement surgery, and for the treatment of DVT and PE to prevent a recurrence. Apixaban is an inhibitor used to prevent stroke and systemic embolism in individuals with nonvalvular atrial fibrillation, as well as deep vein thrombosis (DVT) leading to pulmonary embolism (PE) in people who have had hip or knee replacement surgery. Apixaban is an antithrombin III-independent, oral, direct, and highly selective factor Xa inhibitor that inhibits both free and bound FXa, as well as prothrombinase, for the treatment and prevention of thromboembolic disorders. Eliquis is the brand name for it. On December 28, 2012, the FDA authorized apixaban.

The Wholesale Price of Apixaban

Apixaban can be purchased from any drugstore. A month's supply of Apixaban costs $450-500 in the US, whereas in Europe it costs 80 EUR both for the 2.5mg and the 5mg tablets. The prices may vary highly as per the location of the pharmacy. But the prices may vary widely as per the pharmacy or drugstore location you visit. Wholesale price differs according to the wholesaler of the region or country where the order has been processed for sale. Prices are only valid for cash-paying consumers and do not apply to insurance schemes. Pharmaceutical corporations generally support patient assistance programs (PAPs), which provide free or subsidized drugs to low-income, unemployed, or under-insured individuals who meet certain criteria. Some offers can be downloaded directly from a website, while others need registration, completion of a survey, or the collection of a sample from a physician's office.

Navigating Our Pharmaceutical Marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Apixaban offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for these Apixaban manufacturers and these Apixaban suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Apixaban. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Apixaban is already registered in. Manufacturers also have special, and delivery terms.

Establishing Commercial Ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the Apixaban manufacturers or Apixaban suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are onboarded on the platform. This allows us to screen Apixaban manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.